Resistance is futile: Engineering the Adoptive T-Cell therapies of the future

Eugene Shenderov; Richard F. Ambinder

doi:10.1200/JCO.2017.76.6618

Resistance is futile: Engineering the Adoptive T-Cell therapies of the future

Eugene Shenderov, Richard F. Ambinder

School of Medicine

Research output: Contribution to journal › Short survey › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1140-1142
Number of pages	3
Journal	Journal of Clinical Oncology
Volume	36
Issue number	11
DOIs	https://doi.org/10.1200/JCO.2017.76.6618
State	Published - Apr 10 2018

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2017.76.6618

Cite this

@article{10c83cf785984af6b5c9a16c88433cbf,

title = "Resistance is futile: Engineering the Adoptive T-Cell therapies of the future",

author = "Eugene Shenderov and Ambinder, {Richard F.}",

year = "2018",

month = apr,

day = "10",

doi = "10.1200/JCO.2017.76.6618",

language = "English (US)",

volume = "36",

pages = "1140--1142",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "11",

}

TY - JOUR

T1 - Resistance is futile

T2 - Engineering the Adoptive T-Cell therapies of the future

AU - Shenderov, Eugene

AU - Ambinder, Richard F.

PY - 2018/4/10

Y1 - 2018/4/10

UR - http://www.scopus.com/inward/record.url?scp=85045150197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045150197&partnerID=8YFLogxK

U2 - 10.1200/JCO.2017.76.6618

DO - 10.1200/JCO.2017.76.6618

M3 - Short survey

C2 - 29364774

AN - SCOPUS:85045150197

SN - 0732-183X

VL - 36

SP - 1140

EP - 1142

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 11

ER -

Resistance is futile: Engineering the Adoptive T-Cell therapies of the future

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this